Overexpression of Bmp4 induces microphthalmia by disrupting embryonic neural retina

Baige Li1, Zeyuan Pu1, Keren Liao1

  • 1Eye Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.

Neurobiology of Disease
|August 31, 2024
PubMed

Insights

This study identifies Bone Morphogenetic Protein 4 (Bmp4) as a key gene in microphthalmia, a severe eye malformation. Elevated Bmp4 levels disrupt retinal development, causing cell disorganization and visual impairment.

Area of Science:

  • Developmental Biology
  • Ophthalmology
  • Genetics

Background:

  • Microphthalmia is a severe congenital ocular malformation causing visual impairment.
  • It is often an autosomal dominant disorder with numerous associated genes.

Purpose of the Study:

  • To identify key genes involved in microphthalmia.
  • To elucidate the role of Bone Morphogenetic Protein 4 (Bmp4) in retinal development and microphthalmia pathogenesis.

Main Methods:

  • Bioinformatic analysis using CytoHubba and Protein-Protein Interaction (PPI) networks to identify hub genes.
  • Conditional overexpression of Bmp4 in mouse retinas.
  • Histological analysis and cell counting in microphthalmia models.

Main Results:

  • Identified 30 genes associated with microphthalmia, with Bmp4 emerging as a pivotal hub gene.
  • Conditional Bmp4 overexpression in the retina induced microphthalmia, characterized by retinal disorganization and ganglion cell misalignment.
  • Elevated Bmp4 led to reduced retinal cell numbers, abnormal cell distribution, increased apoptosis, and decreased proliferation.

Conclusions:

  • Bmp4 is a critical gene in microphthalmia development.
  • Aberrant Bmp4 levels disrupt embryonic retinal development, leading to microphthalmia.
  • Maintaining a balanced Bmp4 level is essential for normal embryonic retinal formation.